Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants

Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants

Show other versions (2)

Objective: Urinary tract infection (UTI) caused by resistant strains of bacteria is increasingly prevalent in children. The aim of this study was to investigate the clinical characteristics and risk factors for UTI caused by community-acquired extended-spectrum β-lactamase (CA-ESBL)-producing bacter...

Full description

Bibliographic Details
Main Authors:	Yun Hee Kim, Eun Mi Yang, Chan Jong Kim
Format:	Article
Language:	English
Published:	Elsevier 2017-05-01
Series:	Jornal de Pediatria
Online Access:	http://www.sciencedirect.com/science/article/pii/S0021755716302601

Similar Items

Urinary tract infection caused by community‐acquired extended‐spectrum β‐lactamase‐producing bacteria in infants
by: Yun Hee Kim, et al.
Published: (2017-05-01)

Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants
by: Yun Hee Kim, et al.

Non-carbapenem antimicrobial therapy in young infant with urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing Escherichia coli
by: Kyo Jin Jo, et al.
Published: (2021-05-01)

Extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in São Luís, Brazil
by: Afonso Gomes Abreu, et al.
Published: (2013-01-01)

Persistent Extended-Spectrum β-Lactamase Urinary Tract Infection
by: Joan DeBusscher, et al.
Published: (2009-11-01)

Epidemiology of Extended Spectrum Β-Lactamase Producing Gram Negative Bacilli of Community Acquired Urinary Tract Infection in Tabriz, Iran
by: Sepehr Taghizadeh, et al.
Published: (2018-02-01)

Multi-drug resistant and extended-spectrum lactamase producing bacteria in pediatric urinary tract infection
by: L.B. Shrestha
Published: (2020-12-01)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
by: K P Ranjan, et al.
Published: (2014-01-01)

Community-acquired Extended-Spectrum β-Lactamase Producers, United States
by: Yohei Doi, et al.
Published: (2007-07-01)

Extended-spectrum beta-lactamase-producing community-acquired urinary tract infections in children: Chart review of risk factors
by: Sundaram Balasubramanian, et al.
Published: (2018-01-01)

Characterization of metallo-β-lactamase and extended-spectrum β-lactamases producing Escherichia coli isolates from urinary tract infections in southeast of Iran
by: Reza Ghanbarpour, et al.
Published: (2019-06-01)

Extended spectrum beta-lactamase urinary tract infections
by: Omar M Aboumarzouk
Published: (2014-01-01)

Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital
by: Rasool Soltani, et al.
Published: (2014-01-01)

Community-acquired urinary tract infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in Zenica-Doboj Canton, Bosnia and Herzegovina
by: D. Saric, et al.
Published: (2006-08-01)

Clinical Patterns and Seasonal Distribution of Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Bacteria in Children
by: Serkan TURSUN, et al.
Published: (2021-03-01)

Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review
by: Larramendy S, et al.
Published: (2020-11-01)

Risk factor for urinary tract infections caused by Gram-negative Escherichia coli extended spectrum ß lactamase-producing bacteria
by: Ahmad Abdullah Majrashi, et al.
Published: (2020-01-01)

Extended-spectrum-beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function.
by: Poornima Ramadas, et al.
Published: (2014-01-01)

Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales.
by: Judith Álvarez Otero, et al.
Published: (2020-01-01)

Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection
by: Sobhan Ghafourian, et al.

Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae
by: Nadeem Sajjad Raja
Published: (2019-11-01)

Chemical composition and antibacterial activity of Origanum ramonense essential oil on the β-lactamase and extended- spectrum β-lactamase urinary tract isolates
by: Haitham N. Qaralleh
Published: (2018-09-01)

In Silico Analysis of Extended-Spectrum β-Lactamases in Bacteria
by: Patrik Mlynarcik, et al.
Published: (2021-07-01)

Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing and isolates
by: Olivia Senard, et al.
Published: (2019-01-01)

Genomic and phylogenetic analysis of a community-acquired extended-spectrum β-lactamase-producing Escherichia coli ST429 strain recovered from a urinary tract infection
by: Juan Xu, et al.
Published: (2020-09-01)

Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case–control study
by: Franco Castillo-Tokumori, et al.
Published: (2017-02-01)

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
by: Tham J, et al.
Published: (2012-10-01)

Poverty and Community-Acquired Antimicrobial Resistance with Extended-Spectrum β-Lactamase–Producing Organisms, Hyderabad, India
by: Marcella Alsan, et al.
Published: (2018-08-01)

Impact of antibiotic usage on extended-spectrum β-lactamase producing Escherichia coli prevalence
by: Jeong Yeon Kim, et al.
Published: (2021-06-01)

β-lactam susceptibility in extended-spectrum β-lactamase-producing isolates
by: Gopal Nandlal Agrawal, et al.
Published: (2017-01-01)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
by: Luka Bielen, et al.
Published: (2019-06-01)

Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae
by: Takanori Asakura, et al.
Published: (2014-12-01)

Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains
by: Fatemeh Yeganeh-Sefidan, et al.
Published: (2016-05-01)

Cefepime versus extended spectrum β-lactamase-producing Enterobacteriaceae
by: Keite da Silva Nogueira, MSc, et al.
Published: (2011-03-01)

Cefepime versus extended spectrum β-lactamase-producing Enterobacteriaceae
by: Keite da Silva Nogueira, et al.

Extended-spectrum β-Lactamase-producing Flora in Healthy Persons
by: Camilla Rodrigues, et al.
Published: (2005-06-01)

Extended-Spectrum β-Lactamases among Enterobacteriaceae Isolated from Urinary Tract Infections in Gaza Strip, Palestine
by: Ghassan Tayh, et al.
Published: (2019-01-01)

In Vitro Activity of Fosfomycin Trometamol Against Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains Isolated from Community-Acquired Urinary Tract Infections
by: Meliha Çağla SÖNMEZER, et al.
Published: (2016-12-01)

Human contact with dogs and the risk of acquiring antimicrobial resistant and extended-spectrum β-lactamase-producing Escherichia coli
by: Ormandy, E. E.
Published: (2018)

Risk Factors for Colonization with Extended-Spectrum β-Lactamase–producing Bacteria and Intensive Care Unit Admission
by: Anthony D. Harris, et al.
Published: (2007-08-01)